{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:23:54Z","timestamp":1794025434956,"version":"4.8.0"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,11,1]]},"DOI":"10.2169\/internalmedicine.6825-25","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:09:36Z","timestamp":1773094176000},"page":"2929-2933","source":"Crossref","is-referenced-by-count":0,"title":["Early Benralizumab Use for the Successful Treatment of Eosinophilic Granulomatosis with Polyangiitis-associated Peripheral Neuropathy"],"prefix":"10.2169","volume":"65","author":[{"given":"Marie","family":"Sakai","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzuka","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takigawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Neurology Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Shibayama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int 68: 430-436, 2019.","DOI":"10.1016\/j.alit.2019.06.004"},{"key":"2","unstructured":"2. Guidelines for Management of Vasculitis Syndrome (JCS 2017). Scientific Committee of the Japanese Circulation Society, Ed. Tokyo, 2017 (in Japanese)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamanaka N, Takeshita Y, Sato R, et al. Acute therapeutic effects and pathophysiology of eosinophilic granulomatosis with polyangiitis neuropathy. BMJ Neurol Open 7: e000938, 2025.","DOI":"10.1136\/bmjno-2024-000938"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Grayson PC, Ponte C, Suppiah R, et al.; DCVAS Study Group. 2022 American College of Rheumatology\/European Alliance of associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis 81: 309-314, 2022.","DOI":"10.1002\/art.41982"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63: 65-81, 1984.","DOI":"10.1097\/00005792-198403000-00001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Guillevin L, Pagnoux C, Seror R, et al.; the French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90: 19-27, 2011.","DOI":"10.1097\/MD.0b013e318205a4c6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68: 1827-1832, 2009.","DOI":"10.1136\/ard.2008.101279"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Suppiah R, Mukhtyar C, Flossmann O, et al. A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 50: 899-905, 2011.","DOI":"10.1093\/rheumatology\/keq400"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Nishi R, Koike H, Ohyama K, et al. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA. Neurology 94: e1726-e1737, 2020.","DOI":"10.1212\/WNL.0000000000009309"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kolbeck R, Kozhich A, Koike M, et al. MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol 125: 1344-1353, 2010.","DOI":"10.1016\/j.jaci.2010.04.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wechsler ME, Nair P, Terrier B, et al.; the MANDARA Study Group. Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis. N Engl J Med 390: 911-921, 2024.","DOI":"10.1056\/NEJMoa2311155"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nanzer AM, Maynard-Paquette AC, Alam V, et al. Long-term effectiveness of benralizumab in eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol Pract 12: 724-732, 2024.","DOI":"10.1016\/j.jaip.2024.01.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jackson DJ, Shavit A, Ding N, et al. Systematic literature review of real-world outcomes of benralizumab in eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol Pract 13: 3054-3065, 2025.","DOI":"10.1016\/j.jaip.2025.08.028"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Koga Y, Yoshimi S, Harada T, et al. Long-term safety and efficacy of benralizumab for eosinophilic granulomatosis with polyangiitis complicated with severe neuropathy. Intern Med 62: 1553-1556, 2023.","DOI":"10.2169\/internalmedicine.0613-22"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Matsuoka S, Kudo K, Goda M, et al. Life-threating asthma exacerbation successfully treated with benralizumab. Intern Med 64: 2382-2385, 2025.","DOI":"10.2169\/internalmedicine.4737-24"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. P\u00e9rez-de Llano L, Bonilla MG, Luzon E, Ramos-Lima F, Miralles JC. What we know to date about early treatment with biologics in severe asthma: a scoping review about the use of biologics in severe asthma and possible parallels with early rheumatoid arthritis. Open Respir Arch 7: 100418, 2025.","DOI":"10.1016\/j.opresp.2025.100418"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. M\u00fcmmler C, Mertsch P, Barnikel M, et al. Benralizumab reduces respiratory exacerbations and oral glucocorticosteroid dose in patients with severe asthma and eosinophilic granulomatosis with polyangiitis. J Asthma Allergy 17: 557-572, 2024.","DOI":"10.2147\/JAA.S461800"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_6825-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:33:27Z","timestamp":1794022407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_6825-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":17,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6825-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,1]]},"article-number":"6825-25"}}